van Kempen ML - Search Results

1

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.

Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Verdonck LF, et al. Among authors: van kempen ml. Blood. 1994 May 15;83(10):3090-6. Blood. 1994. PMID: 8180405 Free article.

2

Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.

Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Verdonck LF, et al. Among authors: van kempen ml. J Clin Oncol. 1992 Dec;10(12):1949-54. doi: 10.1200/JCO.1992.10.12.1949. J Clin Oncol. 1992. PMID: 1453209

3

Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancy.

Verdonck LF, Dekker AW, van Kempen ML, Punt K, van Unnik JA, van Peperzeel HA, de Gast GC. Verdonck LF, et al. Among authors: van kempen ml. Blood. 1985 Apr;65(4):984-9. Blood. 1985. PMID: 3884064 Free article.

4

Intensive cytoreductive therapy followed by autologous bone marrow transplantation for patients with hematologic malignancies or solid tumors.

Verdonck LF, Dekker AW, Vendrik PJ, van Kempen ML, Schornagel JH, Rozenberg-Arska M, de Gast GC. Verdonck LF, et al. Among authors: van kempen ml. Cancer. 1987 Aug 1;60(3):289-95. doi: 10.1002/1097-0142(19870801)60:3<289::aid-cncr2820600304>3.0.co;2-8. Cancer. 1987. PMID: 3297283

5

Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.

Verdonck LF, Dekker AW, van Heugten H, van Kempen ML, Punt K, de Gast GC. Verdonck LF, et al. Among authors: van kempen ml. Haematol Blood Transfus. 1987;30:563-6. doi: 10.1007/978-3-642-71213-5_101. Haematol Blood Transfus. 1987. PMID: 3305219 No abstract available.

6

[High dose cytotoxic agents followed by autologous bone marrow transplantation; treatment results in 25 patients with various malignancies].

Verdonck LF, Vendrik CP, Dekker AW, van Kempen ML, Schornagel JH, Rozenberg-Arska M, de Gast GC. Verdonck LF, et al. Among authors: van kempen ml. Ned Tijdschr Geneeskd. 1985 Jun 22;129(25):1186-90. Ned Tijdschr Geneeskd. 1985. PMID: 3895000 Dutch. No abstract available.

7

Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis.

van der Linden YM, van Kempen ML, van der Tweel I, Vanderschueren RG, Schlösser NJ, Lammers JW, Struikmans H. van der Linden YM, et al. Among authors: van kempen ml. Respir Med. 2001 Mar;95(3):235-6. doi: 10.1053/rmed.2000.1022. Respir Med. 2001. PMID: 11266242 Free article.

8

Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing.

van de Glind G, Rebel H, van Kempen M, Tensen K, de Gruijl F. van de Glind G, et al. Oncotarget. 2016 Feb 16;7(7):8067-77. doi: 10.18632/oncotarget.6932. Oncotarget. 2016. PMID: 26797757 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters